LUPRON DEPOT 3.75 mg is a gonadotropin-releasing hormone (GnRH) agonist indicated for: Endometriosis Management of endometriosis, including pain relief and reduction of endometriotic lesions. In combination with a norethindrone acetate for initial management of the painful symptoms of endometriosis and for management of recurrence of symptoms.
From the U.S. FDA-approved label for Leuprolide acetate. Full label: DailyMed.
LUPRON DEPOT 3.75 mg is a gonadotropin-releasing hormone (GnRH) agonist indicated for: Endometriosis Management of endometriosis, including pain relief and reduction of endometriotic lesions. In combination with a norethindrone acetate for initial management of the painful symptoms of endometriosis and for management of recurrence of symptoms.
From the U.S. FDA-approved label for Leuprolide acetate. Full label: DailyMed.
LUPRON DEPOT 3.75 mg for 1-month administration, given by a healthcare provider as a single intramuscular injection. LUPRON DEPOT 3.75 mg has different release characteristics than LUPRON 11.25 mg and is dosed differently. Do not substitute LUPRON DEPOT 3.75 mg for LUPRON DEPOT 11.25 mg.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
LUPRON DEPOT 3.75 mg is contraindicated in women with the following: Hypersensitivity to gonadotropin-releasing hormone (GnRH), GnRH agonist analogs, including leuprolide acetate, or any of the excipients in LUPRON DEPOT 3.75 mg Undiagnosed abnormal uterine bleeding Pregnancy When norethindrone acetate is administered with LUPRON DEPOT 3.75 mg, the contraindications to the use of norethindrone acetate also apply to this combination regimen.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Loss of bone mineral density (BMD): Duration of treatment is limited by risk of bone mineral density. When using for management of endometriosis: combination use with norethindrone acetate is effective in reducing loss of BMD; do not retreat without combination norethindrone acetate. Assess BMD before retreatment. Embryo-Fetal Toxicity: May cause fetal harm. Exclude pregnancy before initiating treatment if clinically indicated and discontinue use if pregnancy occurs. Use non-hormonal methods of contraception only.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described elsewhere in the labeling: Loss of Bone Mineral Density Severe Cutaneous Adverse Reactions Hypersensitivity Reactions Initial Flare of Symptoms with Management of Endometriosis Convulsions Clinical Depression Most common adverse reactions (>10%) in clinical trials were hot flashes/sweats, headache/migraine, vaginitis, depression/emotional lability, general…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
64 products from 29 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Lulizol 1%w/w Cream | Leuprolide acetate (1%w/w) | klm laboratories Pvt Ltd. | |
| Luprid Depot 3.75mg Injection | Leuprolide acetate (3.75mg) | Sun Pharmaceutical Industries Ltd. | |
| Lupride 3.75mg Injection | Leuprolide acetate (3.75mg) | Sun Pharmaceutical Industries Ltd. | |
| Luprodex 3.75mg Injection | Leuprolide acetate (3.75mg) | Bharat Serums & Vaccines Ltd | |
| Luprorin 3.75mg Injection | Leuprolide acetate (3.75mg) | Intas Pharmaceuticals Ltd. | |
| Bdsure 11.25mg Injection | Leuprolide (11.25mg) | BDR Pharmaceuticals Internationals Pvt | vial of 1 Injection |
| Bdsure 22.5mg Injection | Leuprolide (22.5mg) | BDR Pharmaceuticals Internationals Pvt | vial of 1 Injection |
| Bdsure 3.75mg Injection | Leuprolide (3.75mg) | BDR Pharmaceuticals Internationals Pvt | vial of 1 Injection |
| Corlide Depot 3.75mg Injection | Leuprolide (3.75mg) | Chandra Bhagat Pharma Pvt Ltd | vial of 1 Injection |
| Eligard 45mg Injection | Leuprolide (45mg) | Emcure Pharmaceuticals Ltd | packet of 1 Injection |
| Eligard 7.5mg Injection | Leuprolide (7.5mg) | Emcure Pharmaceuticals Ltd | vial of 1 Injection |
| Eligard Depot 22.5mg Injection | Leuprolide (22.5mg) | Emcure Pharmaceuticals Ltd | vial of 1 Injection |
| Eligard Depot 45mg Injection | Leuprolide (45mg) | Emcure Pharmaceuticals Ltd | vial of 10 ml Injection |
| Endorelin 3.75mg Injection | Leuprolide (3.75mg) | Serum Institute Of India Ltd | vial of 1 Injection |
| Eurolide 3.75mg Depot Injection | Leuprolide (3.75mg) | Samarth Life Sciences Pvt Ltd | vial of 1 Injection |
| Eurolide 4mg Injection | Leuprolide (4mg) | Samarth Life Sciences Pvt Ltd | vial of 4 ml Injection |
| Eurolide Injection | Leuprolide (1mg) | Samarth Life Sciences Pvt Ltd | vial of 0.5 ml Injection |
| Glerelin 22.5mg Pre Filled Syringe | Leuprolide (22.5mg) | Glenmark Pharmaceuticals Ltd | vial of 1 Injection |
| Gonadoreg 3.75mg Injection | Leuprolide (3.75mg) | Jagsonpal Pharmaceuticals Ltd | vial of 2 ml Injection |
| Gynact 4mg Injection | Leuprolide (4mg) | Bharat Serums & Vaccines Ltd | vial of 4 ml Injection |
| Gynact Injection | Leuprolide (1mg/ml) | Bharat Serums & Vaccines Ltd | vial of 1 ml Injection |
| Gynact M.D 4mg Injection | Leuprolide (4mg) | Bharat Serums & Vaccines Ltd | vial of 4 ml Injection |
| Ipigone 4mg Injection | Leuprolide (4mg) | Cipla Ltd | vial of 4 ml Injection |
| Leprol 11.25mg Injection | Leuprolide (11.25mg) | Aureate Healthcare Pvt Ltd | vial of 1 Injection |
| Leprol 22.5mg Injection | Leuprolide (22.5mg) | Aureate Healthcare Pvt Ltd | vial of 1 Injection |
| Leufol Depot 3.75mg Injection | Leuprolide (3.75mg) | Vhb Life Sciences Inc | vial of 1 Injection |
| Leupo 11.25mg Injection | Leuprolide (11.25mg) | Intas Pharmaceuticals Ltd | vial of 1 Injection |
| Leupo 22.5mg Injection | Leuprolide (22.5mg) | Intas Pharmaceuticals Ltd | vial of 1 Injection |
| Leuprodex Depot 3.75mg Injection | Leuprolide (3.75mg) | Bharat Serums & Vaccines Ltd | vial of 1 Injection |
| Leuprogon Injection | Leuprolide (3.75mg) | LG Lifesciences | vial of 1 ml Injection |
Showing 30 of 64 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store between 20° to 25°C (68° to 77°F).
Storage information from the U.S. FDA-approved label.
Leuprolide acetate is recorded in the NepalDoc medicine catalog for: Uterine fibroids, Endometriosis, Prostate cancer.
For Endometriosis: Danazol, Norethisterone.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.